Biotech

Catch-all for biotech content not captured by a more specific sub-Sector. Editors must pick a sub-Sector first; only use this term when no sub-Sector applies.
Biotech

Barrick Mining publishes 2025 sustainability report

Barrick's annual ESG disclosure covers safety, biodiversity and Scope 3 supplier engagement across 17 countries.
Barrick's annual ESG disclosure covers safety, biodiversity and Scope 3 supplier engagement across 17 countries.
Disrupts Editorial Team  · 
AI & ML
Biotech

Vector and Helmholtz Munich team up to push AI into biomedicine

Canada's Vector Institute and Germany's Helmholtz Munich formalise an AI research pact targeting precision medicine and biomedical discovery.
Canada's Vector Institute and Germany's Helmholtz Munich formalise an AI research pact targeting precision medicine and biomedical discovery.
Disrupts Editorial Team  · 
AI & ML
Biotech

Profusa shareholder vote tests Nasdaq lifeline for biosensor firm

Profusa's June 23 AGM asks investors to back dilutive measures keeping the tissue-sensor company listed and funding its PanOmics acquisition.
Profusa's June 23 AGM asks investors to back dilutive measures keeping the tissue-sensor company listed and funding its PanOmics acquisition.
Disrupts Editorial Team  · 
AI & ML
Biotech
Datatech

Fangzhou and Tencent Health unite AI agents for chronic disease care

China's largest online chronic disease platform pairs its proprietary LLM with Tencent's cloud infrastructure to shift healthcare from episodic to continuous.
China's largest online chronic disease platform pairs its proprietary LLM with Tencent's cloud infrastructure to shift healthcare from episodic to continuous.
Disrupts Editorial Team  · 
Aerospace
Biotech

Excelitas Files 2025 Sustainability Report

Photonics and sensing supplier Excelitas publishes its second annual ESG report, mapping disclosures to GRI, IFRS S1/S2 and SASB standards.
Photonics and sensing supplier Excelitas publishes its second annual ESG report, mapping disclosures to GRI, IFRS S1/S2 and SASB standards.
Disrupts Editorial Team  · 
Biotech

Xeriant schedules NexBoard fire-certification tests for composite panel

Xeriant's fire-resistant composite panel heads for third-party certification after internal tests surviving 2,000°F flame.
Xeriant's fire-resistant composite panel heads for third-party certification after internal tests surviving 2,000°F flame.
Disrupts Editorial Team  · 
Biotech

NorthStrive licenses multi-domain drone patent for maritime defence

A Nasdaq-listed holding company secures exclusive worldwide rights to buoyancy-assisted drone payload tech as AUKUS and US Navy autonomy spending accelerates.
A Nasdaq-listed holding company secures exclusive worldwide rights to buoyancy-assisted drone payload tech as AUKUS and US Navy autonomy spending accelerates.
Disrupts Editorial Team  · 
AI & ML
Biotech

Thoma Bravo's C$650m Kneat buy targets life sciences compliance tech

The software PE giant's all-cash take-private positions AI-enabled validation as critical infrastructure for regulated industries.
The software PE giant's all-cash take-private positions AI-enabled validation as critical infrastructure for regulated industries.
Disrupts Editorial Team  · 
Space
Biotech

CPI Aero wins Embraer Phenom 100EX inlet deal in aerospace supply shift

CPI Aerostructures secures a life-of-program Embraer contract, extending a dual civil-defence supply chain model that underpins US aerospace consolidation.
CPI Aerostructures secures a life-of-program Embraer contract, extending a dual civil-defence supply chain model that underpins US aerospace consolidation.
Disrupts Editorial Team  · 
AI & ML
Space
Biotech

3D Systems seeks $40m equity raise to fund additive manufacturing push

The additive manufacturing pioneer taps public markets as demand grows across aerospace, medical, and AI infrastructure sectors.
The additive manufacturing pioneer taps public markets as demand grows across aerospace, medical, and AI infrastructure sectors.
Disrupts Editorial Team  · 
Biotech

LanzaTech JV lists in Hong Kong in $75m SAF-carbon IPO

Beijing Shougang LanzaTech's Hong Kong IPO signals capital markets appetite for industrial carbon-to-fuel convergence plays.
Beijing Shougang LanzaTech's Hong Kong IPO signals capital markets appetite for industrial carbon-to-fuel convergence plays.
Disrupts Editorial Team  · 
Biotech

Stellar Alpina raises CHF 3.5M for detonation propulsion in-space

Swiss startup completes Europe's first commercial RDRE hotfire 82 days after founding, targeting the orbital mobility gap left by cheaper launch.
Swiss startup completes Europe's first commercial RDRE hotfire 82 days after founding, targeting the orbital mobility gap left by cheaper launch.
Disrupts Editorial Team  · 
Biotech

Ming Yang eyes BC offshore wind stake in Indigenous-led 2 GW project

A Chinese turbine giant's Canadian MOU signals sovereign-scale clean energy capital crossing geopolitical lines into Indigenous partnership territory.
A Chinese turbine giant's Canadian MOU signals sovereign-scale clean energy capital crossing geopolitical lines into Indigenous partnership territory.
Disrupts Editorial Team  · 
Biotech

CECO Environmental absorbs Thermon in industrial-green convergence deal

CECO's acquisition of process-heating specialist Thermon broadens its energy-transition and industrial-decarbonisation footprint globally.
CECO's acquisition of process-heating specialist Thermon broadens its energy-transition and industrial-decarbonisation footprint globally.
Disrupts Editorial Team  · 
Biotech

CECO and Thermon win near-unanimous shareholder backing for merger

Both industrial firms secure over 99% shareholder approval, with the combined entity set to close around 1 June 2026.
Both industrial firms secure over 99% shareholder approval, with the combined entity set to close around 1 June 2026.
Disrupts Editorial Team  · 
Biotech

ABO-Group pivots to defence and nuclear as construction slows

The Belgian geotechnics firm hit €106.5m revenue in 2025 by trading cyclical construction exposure for defence and nuclear contracts.
The Belgian geotechnics firm hit €106.5m revenue in 2025 by trading cyclical construction exposure for defence and nuclear contracts.
Disrupts Editorial Team  · 
Subscribe to Biotech